Using sigLASSO to optimize cancer mutation signatures jointly with sampling likelihood
Li S, Crawford FW, Gerstein MB. Using sigLASSO to optimize cancer mutation signatures jointly with sampling likelihood. Nature Communications 2020, 11: 3575. PMID: 32681003, PMCID: PMC7368050, DOI: 10.1038/s41467-020-17388-x.Peer-Reviewed Original Research